Stockwatch: Teva, Biogen, Ionis, Sage And The Art Of Strategic News Placement

Earnings announcements from Teva and clinical trial results from Biogen, Ionis and Sage have turned out to have quite different interpretations in retrospect. Exciting news can sometimes look more like a vehicle for strategically timed stock promotion than a genuine material event.